Lanean...
Outcomes Related to Methotrexate Dose and Route of Administration in Patients with Rheumatoid Arthritis: A Systematic Literature Review
OBJECTIVE: Methotrexate (MTX) is considered the “anchor drug” in the therapy of rheumatoid arthritis (RA), yet many physicians do not optimize MTX regimens in spite of high RA disease activity. The recent development of an auto-injector for the subcutaneous (subQ) administration of MTX has prompted...
Gorde:
| Argitaratua izan da: | Clin Exp Rheumatol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406815/ https://ncbi.nlm.nih.gov/pubmed/25536122 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|